Market Indices


Latest News

Guggenheim analyst issues NEUTRAL recommendation for ATAI on July 16,...

July 16, 2026   ATAI 32.73%

Cantor Fitzgerald analyst issues NEUTRAL recommendation for ATAI on July...

July 16, 2026   ATAI 32.73%

Champions Oncology, Inc. (CSBR) confirmed earnings release on July 16, 2026,...

July 16, 2026   CSBR 3.11%

BayCom Corp (BCML) confirmed earnings release on July 16, 2026, Before...

July 16, 2026   BCML 2.34%

Chemung Financial Corporation (CHMG) confirmed earnings release on July 16, 2026,...

July 16, 2026   CHMG 2.33%


Price Targets

from Northland Securities issued a price target of $3.75 for GEVO on 2026-07-16 13:06:14.The adjusted price target was set to $3.75.At the time of the announcement, GEVO...

July 16, 2026   GEVO 1.00%

David Feaster from Raymond James issued a price target of $66.00 for PLBC on 2026-07-16 12:49:52.The adjusted price target was set to $66.00.At the time of the announcement,

July 16, 2026   PLBC 2.52%

from Truist Financial issued a price target of $178.00 for BNY on 2026-07-16 12:02:54.The adjusted price target was set to $178.00.At the time of the announcement, BNY...

July 16, 2026   BNY -1.36%

from Goldman Sachs issued a price target of $177.00 for BNY on 2026-07-16 11:51:47.The adjusted price target was set to $177.00.At the time of the announcement, BNY...

July 16, 2026   BNY -1.36%

Gerard Cassidy from RBC Capital issued a price target of $168.00 for BNY on 2026-07-16 11:48:25.The adjusted price target was set to $168.00.At the time of the announcement,

July 16, 2026   BNY -1.36%



Market Movers

Top Gainers (%)
ATPC
Agape ATP Corporation
4.08
61.91%
ATAI
Atai Beckley Inc.
7.11
32.73%
BZFDW
BuzzFeed, Inc.
0.02
13.29%
CRDL
Cardiol Therapeutics Inc.
1.26
13.06%
OPRT
Oportun Financial Corpora
6.35
11.90%
LCNB
LCNB Corp.
19.99
11.71%
HRTX
Heron Therapeutics, Inc.
0.49
11.28%
MCHX
Marchex, Inc.
1.89
9.88%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP -6.29%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE -9.15%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK -3.68%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN 0.97%